Lifetime physical activity and the risk of amyotrophic lateral sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 9, 2013, Pages 976-981

  Huisman, Mark H B ^a   Seelen, Meinie ^a   De Jong, Sonja W ^a   Dorresteijn, Kirsten R I S ^a   Van Doormaal, Perry T C ^a   Van Der Kooi, Anneke J ^b   De Visser, Marianne ^b   Schelhaas, Helenius Jurgen ^c   Van Den Berg, Leonard H ^a   Veldink, Jan Herman ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c RADBOUD UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; ENERGY COST; FEMALE; HUMAN; LEISURE; MAJOR CLINICAL STUDY; MALE; OCCUPATION; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SPORT; STRUCTURED QUESTIONNAIRE; TRIATHLON;

EID: 84881550852     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-304724     Document Type: Article

References (39)

1. Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet 2011;377:942-55.
2. Lehman EJ, Hein MJ, Baron SL, et al. Neurodegenerative causes of death among retired National Football League players. Neurology 2012;79:1970-4.
3. Chio A, Benzi G, Dossena M, et al. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 2005;128:472-6. (Pubitemid 40380183)
4. Weisskopf MG, O'Reilly EJ, McCullough ML, et al. Prospective study of military service and mortality from ALS. Neurology 2005;64:32-7. (Pubitemid 40082933)
5. Chio A, Calvo A, Dossena M, et al. ALS in Italian professional soccer players: the risk is still present and could be soccer-specific. Amyotroph Lateral Scler 2009;10:205-9.
6. Huisman MH, de Jong SW, Verwijs MC, et al. Family history of neurodegenerative and vascular diseases in ALS: a population-based study. Neurology 2011;77:1363-9.
7. Longstreth WT, Nelson LM, Koepsell TD, et al. Hypotheses to explain the association between vigorous physical activity and amyotrophic lateral sclerosis. Med Hypotheses 1991;34:144-8.
8. Harwood CA, McDermott CJ, Shaw PJ. Physical activity as an exogenous risk factor in motor neuron disease (MND): A review of the evidence. Amyotroph Lateral Scler 2009;10:191-204.
9. Vanacore N, Cocco P, Fadda D, et al. Job strain, hypoxia and risk of amyotrophic lateral sclerosis: Results from a death certificate study. Amyotroph Lateral Scler 2010;11:430-4.
10. Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology 2003;22:217-28. (Pubitemid 36693864)
11. Veldink JH, Kalmijn S, Groeneveld GJ, et al. Physical activity and the association with sporadic ALS. Neurology 2005;64:241-5.
12. Armon C. Sports and trauma in amyotrophic lateral sclerosis revisited. J Neurol Sci 2007;262:45-53. (Pubitemid 47390895)
13. Beghi E, Logroscino G, Chio A, et al. Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study. Amyotroph Lateral Scler 2010;11:289-92.
14. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32: S498-504.
15. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2000;1:293-9.
16. Renton A, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011;72:257-68.
17. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245-56.
18. Ishiura H, Takahashi Y, Mitsui J, et al. C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii Peninsula of Japan. Arch Neurol 2012;69:1154-8.
19. Logroscino G, Traynor BJ, Hardiman O, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 2010;81:385-90.
20. Scarmeas N, Shih T, Stern Y, et al. Premorbid weight, body mass, and varsity athletics in ALS. Neurology 2002;59:773-5.
21. Mattsson P, Lonnstedt I, Nygren I, et al. Physical fitness, but not muscle strength, is a risk factor for death in amyotrophic lateral sclerosis at an early age. J Neurol Neurosurg Psychiatry 2012;83:390-4.
22. Turner MR, Wotton C, Talbot K, et al. Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study. J Neurol Neurosurg Psychiatry 2012;83:395-8.
23. Chio A, Mora G. Physical fitness and amyotrophic lateral sclerosis: dangerous liaisons or common genetic pathways? J Neurol Neurosurg Psychiatry 2012;83:389.
24. Longstreth WT, McGuire V, Koepsell TD, et al. Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study. Arch Neurol 1998;55:201-6.
25. Lee JR, Annegers JF, Appel SH. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 1995;132:207-15.
26. Sorenson EJ, Mandrekar J, Crum B, et al. Effect of referral bias on assessing survival in ALS. Neurology 2007;68:600-2.
27. McGuire V, Longstreth WT Jr, Koepsell TD, et al. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology 1996;47:571-3. (Pubitemid 26324064)
28. Forbes RB, Colville S, Parratt J, et al. The incidence of motor nueron disease in Scotland. J Neurol 2007;254:866-9. (Pubitemid 47222306)
29. Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol 2007;17:643-53. (Pubitemid 47268775)
30. Turner MR, Wicks P, Brownstein CA, et al. Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2011;82:853-4.
31. Ferraiuolo L, De Bono JP, Heath PR, et al. Transcriptional response of the neuromuscular system to exercise training and potential implications for ALS. J Neurochem 2009;109:1714-24.
32. Lambrechts D, Storkebaum E, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003;34:383-94. (Pubitemid 36935331)
33. Zheng C, Nennesmo I, Fadeel B, et al. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann Neurol 2004;56:564-7. (Pubitemid 39319348)
34. Al-Chalabi A, Scheffler MD, Smith BN, et al. Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis. Ann Neurol 2003;54:130-4. (Pubitemid 36764992)
35. Ilieva EV, Ayala V, Jove M, et al. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain 2007;130:3111-23. (Pubitemid 350209064)
36. Hill A Bradford. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
37. Gallo V, Bueno-de-Mesquita HB, Vermeulen R, et al. Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol 2009;65:378-85.
38. Sutedja NA, van der Schouw YT, Fischer K, et al. Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2011;82:638-42.
39. Wicks P. Hypothesis: Higher prenatal testosterone predisposes ALS patients to improved athletic performance and manual professions. Amyotroph Lateral Scler 2012;13:251-3.